# Hasomed GmbH

- Location (FDA's records): Magdeburg, DE
- FDA decisions: 4 (2007–2017): 4 510(k) clearances
- Product codes: GZI (4)
- Predicates its devices cite: 5 (4 its own); citations of its devices by later devices: 5 (4 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Restorative Therapies, Inc.: 1 (https://510kreport.com/company/restorative-therapies)

## Firms that cite its devices most
- Restorative Therapies, Inc.: 1 (https://510kreport.com/company/restorative-therapies)

## Its most-cited devices
- K073237: Rehastim & Rehamove (2007), cited by 2
- K112844: Rehastim 2, Rehamove 2 (2011), cited by 2
- K132416: Rehastim 2, Erigopro (Fes) (2014), cited by 1

## Recent decisions
- K162683: RehaStim 2 (Feb 3, 2017)
- K132416: Rehastim 2, Erigopro (Fes) (May 28, 2014)
- K112844: Rehastim 2, Rehamove 2 (Oct 27, 2011)
- K073237: Rehastim & Rehamove (Dec 27, 2007)

Source page: https://510kreport.com/company/hasomed
